Clearmind Medicine Announces Successful Completion of Treatment and Follow-up for 18 Participants in its Ongoing Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder
Go back to Clearmind Medicine Announces Successful Completion of Treatment and Follow-up for 18 Participants in its Ongoing Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder| (NASDAQ: CMND) | Delayed: 2.30 -0.08 (3.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.38 | 52 Week High | $ | |||
| Open | $2.35 | 52 Week Low | $ | |||
| Day High | $2.42 | P/E | N/A | |||
| Day Low | $2.04 | EPS | $ | |||
| Volume | 4,918,652 | |||||
